S. Mungofa

发表

A Population Pharmacokinetic Analysis Shows that Arylacetamide Deacetylase (AADAC) Gene Polymorphism and HIV Infection Affect the Exposure of Rifapentine

S. Dorman, M. Hatherill, P. Denti, 2019, Antimicrobial Agents and Chemotherapy.

Moxifloxacin Population Pharmacokinetics and Model-Based Comparison of Efficacy between Moxifloxacin and Ofloxacin in African Patients

M. Hatherill, P. Denti, S. Charalambous, 2013, Antimicrobial Agents and Chemotherapy.

The Risk and Timing of Tuberculosis Diagnosed in Smear-Negative TB Suspects: A 12 Month Cohort Study in Harare, Zimbabwe

M. Dimairo, K. Fielding, S. Munyati, 2010, PloS one.

Diagnostic accuracy of commercial urinary lipoarabinomannan detection in African tuberculosis suspects and patients.

M. Dimairo, C. Boehme, S. Munyati, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

A primary care level algorithm for identifying HIV-infected adolescents in populations at high risk through mother-to-child transmission

H. Weiss, R. Ferrand, D. Gibb, 2011, Tropical medicine & international health : TM & IH.

University ’ s repository of research publications and other research outputs Detection of Mycobacterium tuberculosis in sputum by gas chromatography-mass spectrometry of methyl mycocerosates released by thermochemolysis Journal Item

D. Minnikin, O. Lee, R. McNerney, 2018 .

Suboptimal specificity of Xpert MTB/RIF among treatment-experienced patients

P. Hopewell, P. Mason, J. Metcalfe, 2015, European Respiratory Journal.

Detection of Mycobacterium tuberculosis in Sputum by Gas Chromatography-Mass Spectrometry of Methyl Mycocerosates Released by Thermochemolysis

D. Minnikin, O. Lee, R. McNerney, 2012, PloS one.

Typhoid outbreak investigation in Dzivaresekwa, suburb of Harare City, Zimbabwe, 2011

M. Tshimanga, N. Gombe, P. Chonzi, 2014, The Pan African medical journal.

Risk factors for mortality in smear-negative tuberculosis suspects: a cohort study in Harare, Zimbabwe.

M. Dimairo, K. Fielding, S. Munyati, 2011, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Reply to Talbot et al

S. Munyati, E. Corbett, P. Mason, 2005 .

Empiric tuberculosis treatment in retreatment patients in high HIV/tuberculosis-burden settings.

P. Hopewell, P. Mason, J. Metcalfe, 2014, The Lancet. Infectious diseases.

Adult mortality in the cities of Bulawayo and Harare, Zimbabwe: 1979-2008

A. Harries, P. Fujiwara, R. Dlodlo, 2011, Journal of the International AIDS Society.

Barriers to Provider-Initiated Testing and Counselling for Children in a High HIV Prevalence Setting: A Mixed Methods Study

H. Mujuru, R. Ferrand, J. Busza, 2014, PLoS medicine.

High post-exposure prophylaxis uptake but low completion rates and HIV testing follow-up in health workers, Harare, Zimbabwe

A. Harries, T. Apollo, H. Tweya, 2021, Journal of infection in developing countries.

Evaluation of the Antiretroviral Therapy Program at Wilkins Hospital in Zimbabwe.

Vurayai Ruhanya, G. Nyandoro, N. Chin’ombe, 2016 .

Enhancing Psychosocial Support for HIV Positive Adolescents in Harare, Zimbabwe

A. Copas, R. Araya, S. Laver, 2013, PloS one.

High-dose rifapentine with moxifloxacin for pulmonary tuberculosis.

P. Butcher, M. Hatherill, S. Charalambous, 2014, The New England journal of medicine.

Chronic cough in primary health care attendees, Harare, Zimbabwe: diagnosis and impact of HIV infection.

S. Munyati, S. Rusakaniko, E. Corbett, 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Etiology and Antimicrobial Susceptibility of Pathogens Responsible for Urethral Discharge Among Men in Harare, Zimbabwe

P. Mason, S. Takuva, D. Lewis, 2014, Sexually transmitted diseases.

Comparison of two active case-finding strategies for community-based diagnosis of symptomatic smear-positive tuberculosis and control of infectious tuberculosis in Harare, Zimbabwe (DETECTB): a cluster-randomised trial

R. Hayes, Brett Williams, G. Churchyard, 2010, The Lancet.

Burden of HIV among primary school children and feasibility of primary school-linked HIV testing in Harare, Zimbabwe: A mixed methods study

S. Munyati, R. Ferrand, S. Laver, 2013, AIDS care.

Validation of a screening tool to identify older children living with HIV in primary care facilities in high HIV prevalence settings

H. Weiss, G. McHugh, S. Munyati, 2016, AIDS.

Perception of risk of vertically acquired HIV infection and acceptability of provider-initiated testing and counseling among adolescents in Zimbabwe.

R. Ferrand, D. Gibb, E. Corbett, 2011, American journal of public health.

Implementation and Operational Research: The Effectiveness of Routine Opt-Out HIV Testing for Children in Harare, Zimbabwe

H. Mujuru, R. Ferrand, K. Kranzer, 2015, Journal of acquired immune deficiency syndromes.

“You are wasting our drugs”: health service barriers to HIV treatment for sex workers in Zimbabwe

J. Busza, F. Cowan, S. Chidiya, 2013, BMC Public Health.

PerceptionofRiskofVerticallyAcquiredHIVInfectionand AcceptabilityofProvider-InitiatedTestingandCounseling AmongAdolescentsinZimbabwe

R. Ferrand, D. Gibb, E. Corbett, 2011 .

Prevalent infectious tuberculosis in Harare, Zimbabwe: burden, risk factors and implications for control.

R. Hayes, Y. Cheung, Brett Williams, 2009, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

Arylacetamide deacetylase (AADAC) gene polymorphism and HIV infection affect the exposure of Rifapentine: a population pharmacokinetics analysis.

S. Dorman, M. Hatherill, P. Denti, 2019 .

Drug-Resistant Tuberculosis in High-Risk Groups, Zimbabwe

P. Hopewell, P. Mason, J. Metcalfe, 2014, Emerging infectious diseases.

Provider-initiated symptom screening for tuberculosis in Zimbabwe: diagnostic value and the effect of HIV status.

R. Hayes, Y. Cheung, G. Churchyard, 2010, Bulletin of the World Health Organization.

Arylacetamide deacetylase ( AADAC ) gene polymorphism and HIV infection 3 affect the exposure of Rifapentine : a population pharmacokinetics analysis

S. Dorman, M. Hatherill, P. Denti, 2019 .